Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Authors:
- Christelle BahlawaneCBChristelle Bahlawane
- René EulenfeldRERené Eulenfeld
- Monique Y WiesingerMWMonique Y Wiesinger
- Jiali WangJWJiali Wang
- Arnaud MullerAMArnaud Muller
- Andreas GirodAGAndreas Girod
- Petr V NazarovPNPetr V Nazarov
- Kathrin FelschKFKathrin Felsch
- Laurent VallarLVLaurent Vallar
- Thomas SauterTSThomas Sauter
- Venkata P SatagopamVSVenkata P Satagopam
- Serge HaanSHSerge Haan
Open Access
- 31 March 2015
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 13 (1) , 1-21
Abstract
Gastrointestinal stromal tumours (GIST) are mainly characterised by the presence of activating mutations in either of the two receptor tyrosine kinases c-KIT or platelet-derived growth factor receptor-α (PDGFRα). Most mechanistic studies dealing with GIST mutations have focused on c-KIT and far less is known about the signalling characteristics of the mutated PDGFRα proteins. Here, we study the signalling capacities and corresponding transcriptional responses of the different PDGFRα proteins under comparable genomic conditions. We demonstrate that the constitutive signalling via the oncogenic PDGFRα mutants favours a mislocalisation of the receptors and that this modifies the signalling characteristics of the mutated receptors. We show that signalling via the oncogenic PDGFRα mutants is not solely characterised by a constitutive activation of the conventional PDGFRα signalling pathways. In contrast to wild-type PDGFRα signal transduction, the activation of STAT factors (STAT1, STAT3 and STAT5) is an integral part of signalling mediated via mutated PDGF-receptors. Furthermore, this unconventional STAT activation by mutated PDGFRα is already initiated in the endoplasmic reticulum whereas the conventional signalling pathways rather require cell surface expression of the receptor. Finally, we demonstrate that the activation of STAT factors also translates into a biologic response as highlighted by the induction of STAT target genes. We show that the overall oncogenic response is the result of different signatures emanating from different cellular compartments. Furthermore, STAT mediated responses are an integral part of mutated PDGFRα signalling.Keywords
This publication has 67 references indexed in Scilit:
- Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modulesBMC Genomics, 2013
- Predicting missing expression values in gene regulatory networks using a discrete logic modeling optimization guided by network stable statesNucleic Acids Research, 2012
- Signal transducer and activator of transcription 5a/b: Biomarker and therapeutic target in prostate and breast cancerThe International Journal of Biochemistry & Cell Biology, 2011
- Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signaturesNucleic Acids Research, 2010
- Circos: An information aesthetic for comparative genomicsGenome Research, 2009
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosageBlood, 2007
- Neoplasia Driven by Mutant c-KIT Is Mediated by Intracellular, Not Plasma Membrane, Receptor SignalingMolecular and Cellular Biology, 2007
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- STATs in oncogenesisOncogene, 2000